25 XP   0   0   10

Baolingbao Biology Co Ltd
Buy, Hold or Sell?

Let's analyse Baolingbao Biology Co Ltd together

PenkeI guess you are interested in Baolingbao Biology Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Baolingbao Biology Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Baolingbao Biology Co Ltd

I send you an email if I find something interesting about Baolingbao Biology Co Ltd.

Quick analysis of Baolingbao Biology Co Ltd (30 sec.)










What can you expect buying and holding a share of Baolingbao Biology Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.07
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥5.35
Expected worth in 1 year
¥5.19
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
¥0.37
Return On Investment
5.9%

For what price can you sell your share?

Current Price per Share
¥6.29
Expected price per share
¥4.5663816793893 - ¥7.6533243107769
How sure are you?
50%

1. Valuation of Baolingbao Biology Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥6.29

Intrinsic Value Per Share

¥-4.40 - ¥5.72

Total Value Per Share

¥0.95 - ¥11.07

2. Growth of Baolingbao Biology Co Ltd (5 min.)




Is Baolingbao Biology Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$273.9m$276.7m-$2.8m-1.1%

How much money is Baolingbao Biology Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$7.4m$18.3m-$10.9m-146.8%
Net Profit Margin2.1%4.9%--

How much money comes from the company's main activities?

3. Financial Health of Baolingbao Biology Co Ltd (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#186 / 1007

Most Revenue
#105 / 1007

Most Profit
#135 / 1007

Most Efficient
#150 / 1007

What can you expect buying and holding a share of Baolingbao Biology Co Ltd? (5 min.)

Welcome investor! Baolingbao Biology Co Ltd's management wants to use your money to grow the business. In return you get a share of Baolingbao Biology Co Ltd.

What can you expect buying and holding a share of Baolingbao Biology Co Ltd?

First you should know what it really means to hold a share of Baolingbao Biology Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Baolingbao Biology Co Ltd is ¥6.29. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Baolingbao Biology Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Baolingbao Biology Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥5.35. Based on the TTM, the Book Value Change Per Share is ¥-0.04 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.52 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.13 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Baolingbao Biology Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.020.3%0.020.3%0.050.8%0.040.6%0.030.4%
Usd Book Value Change Per Share-0.01-0.1%-0.01-0.1%0.071.1%0.030.5%0.020.3%
Usd Dividend Per Share0.020.3%0.020.3%0.020.3%0.020.2%0.010.2%
Usd Total Gains Per Share0.010.2%0.010.2%0.091.4%0.050.8%0.030.5%
Usd Price Per Share1.12-1.12-1.26-1.33-1.42-
Price to Earnings Ratio55.78-55.78-25.38-50.85-75.45-
Price-to-Total Gains Ratio87.22-87.22-13.85-45.82-66.46-
Price to Book Ratio1.52-1.52-1.69-2.01-2.35-
Price-to-Total Gains Ratio87.22-87.22-13.85-45.82-66.46-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.868649
Number of shares1151
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.020.02
Usd Book Value Change Per Share-0.010.03
Usd Total Gains Per Share0.010.05
Gains per Quarter (1151 shares)14.8055.65
Gains per Year (1151 shares)59.19222.60
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
185-264971151213
2171-52108142303436
3256-78167214454659
4341-105226285606882
5427-1312853567571105
6512-1573444279091328
7597-18340349810601551
8683-20946256912111774
9768-23552164113631997
10853-26158071215142220

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%18.00.00.0100.0%
Book Value Change Per Share0.01.00.00.0%2.01.00.066.7%4.01.00.080.0%9.01.00.090.0%17.01.00.094.4%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%18.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%18.00.00.0100.0%

Fundamentals of Baolingbao Biology Co Ltd

About Baolingbao Biology Co Ltd

Baolingbao Biology Co.,Ltd. researches and develops, manufactures, and sells a range of functional sugars in China. The company offers prebiotics, such as isomaltooligosaccharides, galactooligosaccharides, fructooligosaccharides, bagasse trisaccharides, and xylooligosaccharides; sugar alcohols and new sugar source products, including erythritol, trehalose, crystalline fructose, alodonose, and maltose; dietary fiber products comprising polydextrose and resistant dextrin; modified, waxy maize, and corn starch products; starch sugar products, including oligomaltose, fructose syrup, solid corn syrup, maltodextrin, and glucose syrup; and animal nutrition products comprising baolekang and fubaokang. Its products are used in various applications, such as dairy products, drinks, snacks, health products and dietary supplements, candy, special food items, chemicals for daily use, and animal nutrition. The company also exports its products. Baolingbao Biology Co.,Ltd. was founded in 1997 and is based in Yucheng, China.

Fundamental data was last updated by Penke on 2024-04-14 14:38:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is underpriced.

1.1. Profitability of Baolingbao Biology Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Baolingbao Biology Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Baolingbao Biology Co Ltd to the Biotechnology industry mean.
  • A Net Profit Margin of 2.1% means that ¥0.02 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Baolingbao Biology Co Ltd:

  • The MRQ is 2.1%. The company is making a profit. +1
  • The TTM is 2.1%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ2.1%TTM2.1%0.0%
TTM2.1%YOY4.9%-2.8%
TTM2.1%5Y3.7%-1.6%
5Y3.7%10Y3.4%+0.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.1%-207.2%+209.3%
TTM2.1%-218.5%+220.6%
YOY4.9%-282.4%+287.3%
5Y3.7%-432.2%+435.9%
10Y3.4%-593.8%+597.2%
1.1.2. Return on Assets

Shows how efficient Baolingbao Biology Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Baolingbao Biology Co Ltd to the Biotechnology industry mean.
  • 2.0% Return on Assets means that Baolingbao Biology Co Ltd generated ¥0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Baolingbao Biology Co Ltd:

  • The MRQ is 2.0%. Using its assets, the company is less efficient in making profit.
  • The TTM is 2.0%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ2.0%TTM2.0%0.0%
TTM2.0%YOY4.4%-2.4%
TTM2.0%5Y3.3%-1.3%
5Y3.3%10Y2.6%+0.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.0%-13.2%+15.2%
TTM2.0%-12.6%+14.6%
YOY4.4%-11.5%+15.9%
5Y3.3%-13.7%+17.0%
10Y2.6%-15.5%+18.1%
1.1.3. Return on Equity

Shows how efficient Baolingbao Biology Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Baolingbao Biology Co Ltd to the Biotechnology industry mean.
  • 2.7% Return on Equity means Baolingbao Biology Co Ltd generated ¥0.03 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Baolingbao Biology Co Ltd:

  • The MRQ is 2.7%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 2.7%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ2.7%TTM2.7%0.0%
TTM2.7%YOY6.6%-3.9%
TTM2.7%5Y5.2%-2.4%
5Y5.2%10Y4.0%+1.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.7%-16.7%+19.4%
TTM2.7%-15.8%+18.5%
YOY6.6%-14.4%+21.0%
5Y5.2%-19.0%+24.2%
10Y4.0%-19.9%+23.9%

1.2. Operating Efficiency of Baolingbao Biology Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Baolingbao Biology Co Ltd is operating .

  • Measures how much profit Baolingbao Biology Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Baolingbao Biology Co Ltd to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Baolingbao Biology Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY6.2%-6.2%
TTM-5Y4.1%-4.1%
5Y4.1%10Y3.8%+0.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--286.5%+286.5%
TTM--229.1%+229.1%
YOY6.2%-288.4%+294.6%
5Y4.1%-480.7%+484.8%
10Y3.8%-624.7%+628.5%
1.2.2. Operating Ratio

Measures how efficient Baolingbao Biology Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.88 means that the operating costs are ¥1.88 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Baolingbao Biology Co Ltd:

  • The MRQ is 1.882. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.882. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.882TTM1.8820.000
TTM1.882YOY1.823+0.060
TTM1.8825Y1.834+0.048
5Y1.83410Y1.732+0.102
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8823.231-1.349
TTM1.8823.307-1.425
YOY1.8233.774-1.951
5Y1.8345.667-3.833
10Y1.7327.558-5.826

1.3. Liquidity of Baolingbao Biology Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Baolingbao Biology Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 1.36 means the company has ¥1.36 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Baolingbao Biology Co Ltd:

  • The MRQ is 1.363. The company is just able to pay all its short-term debts.
  • The TTM is 1.363. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.363TTM1.3630.000
TTM1.363YOY1.311+0.052
TTM1.3635Y1.191+0.172
5Y1.19110Y1.143+0.048
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3633.890-2.527
TTM1.3634.182-2.819
YOY1.3115.343-4.032
5Y1.1916.135-4.944
10Y1.1436.453-5.310
1.3.2. Quick Ratio

Measures if Baolingbao Biology Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Baolingbao Biology Co Ltd to the Biotechnology industry mean.
  • A Quick Ratio of 0.40 means the company can pay off ¥0.40 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Baolingbao Biology Co Ltd:

  • The MRQ is 0.397. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.397. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.397TTM0.3970.000
TTM0.397YOY0.308+0.089
TTM0.3975Y0.330+0.067
5Y0.33010Y0.458-0.128
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3973.528-3.131
TTM0.3974.059-3.662
YOY0.3085.390-5.082
5Y0.3306.138-5.808
10Y0.4586.488-6.030

1.4. Solvency of Baolingbao Biology Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Baolingbao Biology Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Baolingbao Biology Co Ltd to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.25 means that Baolingbao Biology Co Ltd assets are financed with 25.4% credit (debt) and the remaining percentage (100% - 25.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Baolingbao Biology Co Ltd:

  • The MRQ is 0.254. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.254. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.254TTM0.2540.000
TTM0.254YOY0.333-0.079
TTM0.2545Y0.351-0.097
5Y0.35110Y0.306+0.045
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2540.339-0.085
TTM0.2540.337-0.083
YOY0.3330.273+0.060
5Y0.3510.368-0.017
10Y0.3060.391-0.085
1.4.2. Debt to Equity Ratio

Measures if Baolingbao Biology Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Baolingbao Biology Co Ltd to the Biotechnology industry mean.
  • A Debt to Equity ratio of 34.1% means that company has ¥0.34 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Baolingbao Biology Co Ltd:

  • The MRQ is 0.341. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.341. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.341TTM0.3410.000
TTM0.341YOY0.500-0.159
TTM0.3415Y0.551-0.210
5Y0.55110Y0.460+0.090
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3410.388-0.047
TTM0.3410.403-0.062
YOY0.5000.342+0.158
5Y0.5510.432+0.119
10Y0.4600.461-0.001

2. Market Valuation of Baolingbao Biology Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Baolingbao Biology Co Ltd generates.

  • Above 15 is considered overpriced but always compare Baolingbao Biology Co Ltd to the Biotechnology industry mean.
  • A PE ratio of 55.78 means the investor is paying ¥55.78 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Baolingbao Biology Co Ltd:

  • The EOD is 43.213. Based on the earnings, the company is overpriced. -1
  • The MRQ is 55.785. Based on the earnings, the company is expensive. -2
  • The TTM is 55.785. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD43.213MRQ55.785-12.572
MRQ55.785TTM55.7850.000
TTM55.785YOY25.380+30.405
TTM55.7855Y50.846+4.939
5Y50.84610Y75.451-24.605
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD43.213-2.249+45.462
MRQ55.785-2.553+58.338
TTM55.785-2.669+58.454
YOY25.380-4.107+29.487
5Y50.846-6.247+57.093
10Y75.451-6.499+81.950
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Baolingbao Biology Co Ltd:

  • The EOD is 17.932. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 23.150. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 23.150. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD17.932MRQ23.150-5.217
MRQ23.150TTM23.1500.000
TTM23.150YOY-15.107+38.257
TTM23.1505Y21.278+1.872
5Y21.27810Y3.002+18.276
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD17.932-2.858+20.790
MRQ23.150-3.288+26.438
TTM23.150-3.552+26.702
YOY-15.107-5.560-9.547
5Y21.278-8.326+29.604
10Y3.002-8.881+11.883
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Baolingbao Biology Co Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.52 means the investor is paying ¥1.52 for each ¥1 in book value.

Let's take a look of the Price to Book Ratio trends of Baolingbao Biology Co Ltd:

  • The EOD is 1.176. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.518. Based on the equity, the company is underpriced. +1
  • The TTM is 1.518. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.176MRQ1.518-0.342
MRQ1.518TTM1.5180.000
TTM1.518YOY1.686-0.168
TTM1.5185Y2.009-0.491
5Y2.00910Y2.352-0.343
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.1761.929-0.753
MRQ1.5182.090-0.572
TTM1.5182.091-0.573
YOY1.6862.881-1.195
5Y2.0093.545-1.536
10Y2.3523.936-1.584
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Baolingbao Biology Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.041-0.0410%0.515-108%0.238-117%0.148-128%
Book Value Per Share--5.3505.3500%5.391-1%4.831+11%4.439+21%
Current Ratio--1.3631.3630%1.311+4%1.191+14%1.143+19%
Debt To Asset Ratio--0.2540.2540%0.333-24%0.351-28%0.306-17%
Debt To Equity Ratio--0.3410.3410%0.500-32%0.551-38%0.460-26%
Dividend Per Share--0.1340.1340%0.141-5%0.112+20%0.097+38%
Eps--0.1460.1460%0.358-59%0.255-43%0.183-21%
Free Cash Flow Per Share--0.3510.3510%-0.602+272%0.186+88%0.065+440%
Free Cash Flow To Equity Per Share--0.3510.3510%-0.432+223%0.070+401%0.119+194%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--5.717--------
Intrinsic Value_10Y_min---4.403--------
Intrinsic Value_1Y_max--0.270--------
Intrinsic Value_1Y_min---0.099--------
Intrinsic Value_3Y_max--1.042--------
Intrinsic Value_3Y_min---0.595--------
Intrinsic Value_5Y_max--2.093--------
Intrinsic Value_5Y_min---1.415--------
Market Cap2332149640.320-29%3010660584.9603010660584.9600%3379779261.000-11%3575503938.664-16%3805487794.868-21%
Net Profit Margin--0.0210.0210%0.049-56%0.037-43%0.034-37%
Operating Margin----0%0.062-100%0.041-100%0.038-100%
Operating Ratio--1.8821.8820%1.823+3%1.834+3%1.732+9%
Pb Ratio1.176-29%1.5181.5180%1.686-10%2.009-24%2.352-35%
Pe Ratio43.213-29%55.78555.7850%25.380+120%50.846+10%75.451-26%
Price Per Share6.290-29%8.1208.1200%9.090-11%9.630-16%10.257-21%
Price To Free Cash Flow Ratio17.932-29%23.15023.1500%-15.107+165%21.278+9%3.002+671%
Price To Total Gains Ratio67.565-29%87.22287.2220%13.845+530%45.821+90%66.461+31%
Quick Ratio--0.3970.3970%0.308+29%0.330+20%0.458-13%
Return On Assets--0.0200.0200%0.044-54%0.033-38%0.026-23%
Return On Equity--0.0270.0270%0.066-59%0.052-47%0.040-31%
Total Gains Per Share--0.0930.0930%0.657-86%0.350-73%0.246-62%
Usd Book Value--273919391.333273919391.3330%276799748.173-1%247680085.695+11%227453170.909+20%
Usd Book Value Change Per Share---0.006-0.0060%0.071-108%0.033-117%0.020-128%
Usd Book Value Per Share--0.7390.7390%0.744-1%0.667+11%0.613+21%
Usd Dividend Per Share--0.0190.0190%0.020-5%0.015+20%0.013+38%
Usd Eps--0.0200.0200%0.049-59%0.035-43%0.025-21%
Usd Free Cash Flow--17960168.98017960168.9800%-30896323.522+272%9522675.971+89%2323573.335+673%
Usd Free Cash Flow Per Share--0.0480.0480%-0.083+272%0.026+88%0.009+440%
Usd Free Cash Flow To Equity Per Share--0.0480.0480%-0.060+223%0.010+401%0.016+194%
Usd Market Cap322069865.328-29%415772226.783415772226.7830%466747515.944-11%493777093.929-16%525537864.471-21%
Usd Price Per Share0.869-29%1.1211.1210%1.255-11%1.330-16%1.416-21%
Usd Profit--7453121.6217453121.6210%18390616.680-59%13086711.267-43%9399065.120-21%
Usd Revenue--348552524.469348552524.4690%374630128.326-7%327611443.779+6%257739195.857+35%
Usd Total Gains Per Share--0.0130.0130%0.091-86%0.048-73%0.034-62%
 EOD+4 -4MRQTTM+0 -0YOY+12 -235Y+18 -1710Y+18 -17

3.2. Fundamental Score

Let's check the fundamental score of Baolingbao Biology Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1543.213
Price to Book Ratio (EOD)Between0-11.176
Net Profit Margin (MRQ)Greater than00.021
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.397
Current Ratio (MRQ)Greater than11.363
Debt to Asset Ratio (MRQ)Less than10.254
Debt to Equity Ratio (MRQ)Less than10.341
Return on Equity (MRQ)Greater than0.150.027
Return on Assets (MRQ)Greater than0.050.020
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Baolingbao Biology Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5059.169
Ma 20Greater thanMa 505.911
Ma 50Greater thanMa 1005.924
Ma 100Greater thanMa 2006.731
OpenGreater thanClose6.140
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets2,658,892
Total Liabilities675,407
Total Stockholder Equity1,983,486
 As reported
Total Liabilities 675,407
Total Stockholder Equity+ 1,983,486
Total Assets = 2,658,892

Assets

Total Assets2,658,892
Total Current Assets785,867
Long-term Assets1,873,025
Total Current Assets
Cash And Cash Equivalents 242,736
Net Receivables 229,110
Inventory 278,582
Other Current Assets 216
Total Current Assets  (as reported)785,867
Total Current Assets  (calculated)750,645
+/- 35,223
Long-term Assets
Property Plant Equipment 1,432,683
Intangible Assets 121,281
Long-term Assets Other 1,905
Long-term Assets  (as reported)1,873,025
Long-term Assets  (calculated)1,555,869
+/- 317,156

Liabilities & Shareholders' Equity

Total Current Liabilities576,475
Long-term Liabilities98,932
Total Stockholder Equity1,983,486
Total Current Liabilities
Short Long Term Debt 209,814
Accounts payable 237,559
Other Current Liabilities 1,085
Total Current Liabilities  (as reported)576,475
Total Current Liabilities  (calculated)448,458
+/- 128,017
Long-term Liabilities
Long term Debt 37,900
Capital Lease Obligations Min Short Term Debt245
Long-term Liabilities  (as reported)98,932
Long-term Liabilities  (calculated)38,145
+/- 60,787
Total Stockholder Equity
Retained Earnings 648,203
Total Stockholder Equity (as reported)1,983,486
Total Stockholder Equity (calculated)648,203
+/- 1,335,283
Other
Capital Stock370,771
Common Stock Shares Outstanding 370,771
Net Debt 4,978
Net Invested Capital 2,231,199
Net Working Capital 209,393
Property Plant and Equipment Gross 2,334,392



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
> Total Assets 
507,933
601,896
743,907
1,084,110
1,032,573
1,112,589
1,112,767
1,675,390
1,766,097
1,913,550
1,931,564
2,106,920
2,579,253
2,518,762
2,615,727
3,028,996
3,006,135
2,658,892
2,658,8923,006,1353,028,9962,615,7272,518,7622,579,2532,106,9201,931,5641,913,5501,766,0971,675,3901,112,7671,112,5891,032,5731,084,110743,907601,896507,933
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
624,965
622,871
756,909
926,552
945,567
1,008,156
1,314,886
995,777
785,867
785,867995,7771,314,8861,008,156945,567926,552756,909622,871624,965000000000
       Cash And Cash Equivalents 
120,196
49,074
152,919
395,366
152,528
138,017
129,324
361,316
123,266
274,330
262,883
231,175
416,276
415,992
485,251
585,440
375,949
242,736
242,736375,949585,440485,251415,992416,276231,175262,883274,330123,266361,316129,324138,017152,528395,366152,91949,074120,196
       Short-term Investments 
0
0
0
0
0
0
0
0
270,000
50,000
50,000
90,000
0
0
0
106,670
0
0
00106,67000090,00050,00050,000270,00000000000
       Net Receivables 
62,210
46,367
60,432
75,412
133,418
132,365
140,132
111,988
90,813
121,859
132,535
165,769
275,246
325,693
206,597
303,291
234,259
229,110
229,110234,259303,291206,597325,693275,246165,769132,535121,85990,813111,988140,132132,365133,41875,41260,43246,36762,210
       Other Current Assets 
11,348
11,638
5,338
21,436
26,397
20,708
3,480
214,415
42,870
46,839
24,247
97,219
14,211
18,147
14,910
34,392
33,640
216
21633,64034,39214,91018,14714,21197,21924,24746,83942,870214,4153,48020,70826,39721,4365,33811,63811,348
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
1,308,693
1,350,011
1,652,701
1,573,195
1,607,572
1,714,110
2,010,359
1,873,025
1,873,0252,010,3591,714,1101,607,5721,573,1951,652,7011,350,0111,308,6930000000000
       Property Plant Equipment 
185,203
364,928
418,017
537,744
614,156
704,177
719,985
814,327
924,311
1,070,372
1,074,034
1,116,218
1,200,609
1,177,019
1,224,364
1,286,352
1,532,285
1,432,683
1,432,6831,532,2851,286,3521,224,3641,177,0191,200,6091,116,2181,074,0341,070,372924,311814,327719,985704,177614,156537,744418,017364,928185,203
       Long Term Investments 
0
0
0
0
0
0
0
0
0
67,843
86,445
87,147
256,202
0
0
0
0
0
00000256,20287,14786,44567,843000000000
       Intangible Assets 
59,170
61,203
59,796
79,250
2,536
2,224
1,922
1,471
110,320
133,000
143,451
140,364
137,677
134,927
133,602
129,266
125,066
121,281
121,281125,066129,266133,602134,927137,677140,364143,451133,000110,3201,4711,9222,2242,53679,25059,79661,20359,170
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
875
1,980
44,781
241
2,351
8,890
646
1,905
1,9056468,8902,35124144,7811,9808750000000000
> Total Liabilities 
395,403
408,619
505,853
421,496
329,460
352,057
295,314
240,877
316,694
435,436
423,431
581,794
1,037,269
951,764
1,016,368
1,215,764
1,001,793
675,407
675,4071,001,7931,215,7641,016,368951,7641,037,269581,794423,431435,436316,694240,877295,314352,057329,460421,496505,853408,619395,403
   > Total Current Liabilities 
370,311
236,927
282,361
360,954
291,360
332,804
268,155
206,275
280,483
402,737
387,820
548,930
984,519
898,728
956,406
1,119,840
759,460
576,475
576,475759,4601,119,840956,406898,728984,519548,930387,820402,737280,483206,275268,155332,804291,360360,954282,361236,927370,311
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
136,657
260,457
499,000
0
0
0
0
0
00000499,000260,457136,6570000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
136,657
260,457
499,000
490,000
235,336
369,178
244,172
209,814
209,814244,172369,178235,336490,000499,000260,457136,6570000000000
       Accounts payable 
77,753
24,680
43,251
35,717
75,699
109,851
89,520
85,072
175,435
239,116
203,380
245,452
291,574
357,988
662,904
634,376
314,157
237,559
237,559314,157634,376662,904357,988291,574245,452203,380239,116175,43585,07289,520109,85175,69935,71743,25124,68077,753
       Other Current Liabilities 
37,088
31,067
14,930
10,057
9,069
54,086
34,043
24,546
28,891
19,267
28,814
22,567
167,841
19,292
30,063
73,297
76,775
1,085
1,08576,77573,29730,06319,292167,84122,56728,81419,26728,89124,54634,04354,0869,06910,05714,93031,06737,088
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
35,611
32,864
52,750
53,036
59,962
95,924
242,333
98,932
98,932242,33395,92459,96253,03652,75032,86435,6110000000000
       Other Liabilities 
0
1,900
7,200
7,750
14,100
19,253
27,159
34,602
36,210
32,698
35,611
32,864
41,958
42,244
49,170
68,943
71,663
0
071,66368,94349,17042,24441,95832,86435,61132,69836,21034,60227,15919,25314,1007,7507,2001,9000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
428
2,444
10,507
7,620
5,483
12,140
18,677
0
018,67712,1405,4837,62010,5072,4444280000000000
> Total Stockholder Equity
112,530
193,276
238,053
662,613
703,113
760,135
817,061
1,434,513
1,449,403
1,478,115
1,505,332
1,522,850
1,540,020
1,566,998
1,599,359
1,813,232
2,004,343
1,983,486
1,983,4862,004,3431,813,2321,599,3591,566,9981,540,0201,522,8501,505,3321,478,1151,449,4031,434,513817,061760,135703,113662,613238,053193,276112,530
   Common Stock
30,200
60,000
60,000
80,000
104,000
104,000
135,200
184,628
369,256
369,256
369,256
369,256
369,256
369,256
369,256
371,912
371,813
0
0371,813371,912369,256369,256369,256369,256369,256369,256369,256184,628135,200104,000104,00080,00060,00060,00030,200
   Retained Earnings 
67,952
11,638
51,937
87,284
121,808
171,958
222,156
235,193
280,584
309,308
336,495
356,577
366,297
390,453
429,237
608,661
719,521
648,203
648,203719,521608,661429,237390,453366,297356,577336,495309,308280,584235,193222,156171,958121,80887,28451,93711,63867,952
   Capital Surplus 000000000000000000
   Treasury Stock000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
-319
-3,447
3,606
6,428
5
29,796
96,771
0
096,77129,79656,4283,606-3,447-3190000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue2,523,914
Cost of Revenue-2,319,382
Gross Profit204,532204,532
 
Operating Income (+$)
Gross Profit204,532
Operating Expense-2,431,840
Operating Income92,074-2,227,308
 
Operating Expense (+$)
Research Development11,299
Selling General Administrative50,067
Selling And Marketing Expenses-
Operating Expense2,431,84061,366
 
Net Interest Income (+$)
Interest Income5,454
Interest Expense-22,678
Other Finance Cost-1,561
Net Interest Income-18,785
 
Pretax Income (+$)
Operating Income92,074
Net Interest Income-18,785
Other Non-Operating Income Expenses-
Income Before Tax (EBT)65,11592,074
EBIT - interestExpense = -22,678
53,969
76,647
Interest Expense22,678
Earnings Before Interest and Taxes (EBIT)-87,793
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax65,115
Tax Provision-11,146
Net Income From Continuing Ops53,96953,969
Net Income53,969
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-18,785
 

Technical Analysis of Baolingbao Biology Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Baolingbao Biology Co Ltd. The general trend of Baolingbao Biology Co Ltd is BEARISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Baolingbao Biology Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-42.9%) Bearish trend (42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Baolingbao Biology Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 6.49 < 6.6 < 7.6533243107769.

The bearish price targets are: 5.13 > 4.5663816793893.

Tweet this
Baolingbao Biology Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Baolingbao Biology Co Ltd. The current mas is .

The long score for the Moving Averages is 4/14.
The longshort score for the Moving Averages is -6/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Baolingbao Biology Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Baolingbao Biology Co Ltd. The current macd is -0.04412059.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Baolingbao Biology Co Ltd price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Baolingbao Biology Co Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Baolingbao Biology Co Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Baolingbao Biology Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartBaolingbao Biology Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Baolingbao Biology Co Ltd. The current adx is 23.52.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Baolingbao Biology Co Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Baolingbao Biology Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Baolingbao Biology Co Ltd. The current sar is 5.1488.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Baolingbao Biology Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Baolingbao Biology Co Ltd. The current rsi is 59.17. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Baolingbao Biology Co Ltd Daily Relative Strength Index (RSI) ChartBaolingbao Biology Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Baolingbao Biology Co Ltd. The current phase is Overbought in bear market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Baolingbao Biology Co Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Baolingbao Biology Co Ltd Daily Stochastic Oscillator ChartBaolingbao Biology Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Baolingbao Biology Co Ltd. The current cci is 84.05.

Baolingbao Biology Co Ltd Daily Commodity Channel Index (CCI) ChartBaolingbao Biology Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Baolingbao Biology Co Ltd. The current cmo is 32.41.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Baolingbao Biology Co Ltd Daily Chande Momentum Oscillator (CMO) ChartBaolingbao Biology Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Baolingbao Biology Co Ltd. The current willr is -17.73049645.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Baolingbao Biology Co Ltd Daily Williams %R ChartBaolingbao Biology Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Baolingbao Biology Co Ltd.

Baolingbao Biology Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Baolingbao Biology Co Ltd. The current atr is 0.25274435.

Baolingbao Biology Co Ltd Daily Average True Range (ATR) ChartBaolingbao Biology Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Baolingbao Biology Co Ltd. The current obv is 29,721,588.

Baolingbao Biology Co Ltd Daily On-Balance Volume (OBV) ChartBaolingbao Biology Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Baolingbao Biology Co Ltd. The current mfi is 53.33.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Baolingbao Biology Co Ltd Daily Money Flow Index (MFI) ChartBaolingbao Biology Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Baolingbao Biology Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-01STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-02CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-18CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-22BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-31ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-20RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-02-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-20BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-03CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-16ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-25CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-30DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside

6.3. Candlestick Patterns

Baolingbao Biology Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Baolingbao Biology Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5059.169
Ma 20Greater thanMa 505.911
Ma 50Greater thanMa 1005.924
Ma 100Greater thanMa 2006.731
OpenGreater thanClose6.140
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Baolingbao Biology Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Baolingbao Biology Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Baolingbao Biology Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Baolingbao Biology Co Ltd

I send you an email if I find something interesting about Baolingbao Biology Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Baolingbao Biology Co Ltd.

Receive notifications about Baolingbao Biology Co Ltd in your mailbox!